National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 10541 [2012-4099]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 35 / Wednesday, February 22, 2012 / Notices
Emphasis Panel; Collaborative Research on
the Transition from Acute to Chronic Pain.
Date: March 12, 2012.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910.
Contact Person: Victor Henriquez, Ph.D.,
Scientific Review Officer, DEA/SRB/NIDCR,
6701 Democracy Blvd., Room 668, Bethesda,
MD 20892–4878, 301–451–2405,
henriquv@nidcr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: February 14, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
srobinson on DSK4SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of IRACDA Grant
Applications.
Date: March 13, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Washington D.C./
Bethesda, 7301 Waverly Street, Bethesda, MD
20814.
Contact Person: Arthur L. Zachary, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.12+, Bethesda, MD
20892–6200, 301–594–2886,
zachary@nigms.nih.gov.
Catalogue of Federal Domestic Assistanve
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Jkt 226001
[FR Doc. 2012–4102 Filed 2–21–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
BILLING CODE 4140–01–P
16:37 Feb 21, 2012
Dated: February 14, 2012.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2012–4103 Filed 2–21–12; 8:45 am]
VerDate Mar<15>2010
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Cooperative Study Group
for Autoimmune Disease Prevention (UO1).
Date: March 12–13, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Hotel—Silver Spring,
8777 Georgia Avenue, Silver Spring, MD
20910.
Contact Person: Andrea L. Wurster, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, Room
3259, 6700B Rockledge Drive, MSC–7616,
Bethesda, MD 20892–761; 301–451–2660,
wurstera@mail.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Predictive Biodosimetry:
Discovery and Development of Biomarkers
for Acute and Delayed Radiation Injuries.
Date: March 15–16, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Maja Maric, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
DHHS/NIH/NIAID, 6700B Rockledge Drive,
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
10541
Room 3266, Bethesda, MD 20892–7616, 301–
451–2634, maja.maric@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; ‘‘PAR–10–271, NIAID
Investigator Initiated Program Project
Applications (P01).’’
Date: March 22, 2012.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Sujata Vijih, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892, 301–594–
0985, vijhs@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 14, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–4099 Filed 2–21–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; SCORE.
Date: March 13, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Washington DC/
Bethesda, 7301 Waverly Street, Bethesda, MD
20814.
Contact Person: Robert Horowits, Ph.D.,
Senior Investigator, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3An.18,
E:\FR\FM\22FEN1.SGM
22FEN1
]]>Agencies
[Federal Register Volume 77, Number 35 (Wednesday, February 22, 2012)]
[Notices]
[Page 10541]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-4099]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Cooperative Study Group for
Autoimmune Disease Prevention (UO1).
Date: March 12-13, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Crowne Plaza Hotel--Silver Spring, 8777 Georgia Avenue,
Silver Spring, MD 20910.
Contact Person: Andrea L. Wurster, Ph.D., Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 3259,
6700B Rockledge Drive, MSC-7616, Bethesda, MD 20892-761; 301-451-
2660, wurstera@mail.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Predictive Biodosimetry: Discovery
and Development of Biomarkers for Acute and Delayed Radiation
Injuries.
Date: March 15-16, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Maja Maric, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, DHHS/
NIH/NIAID, 6700B Rockledge Drive, Room 3266, Bethesda, MD 20892-
7616, 301-451-2634, maja.maric@nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; ``PAR-10-271, NIAID Investigator
Initiated Program Project Applications (P01).''
Date: March 22, 2012.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Sujata Vijih, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301-
594-0985, vijhs@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February 14, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-4099 Filed 2-21-12; 8:45 am]
BILLING CODE 4140-01-P
